News from the healthcare data industry
During his talk at the recent J.P. Morgan Healthcare Conference, Mayo Clinic CEO Gianrico Farrugia laid out a sweeping vision for technology transformation, driven largely by private sector upstarts that...
January 27, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics and Providence Health Plan today announced a collaboration to conduct a Phase 3 study of Cognito’s breakthrough, non-invasive...
Zachary BrennanSenior Editor, Endpoint News Back in late September, the FDA released a long-awaited guidance on how the industry might use electronic health records (EHRs) or medical claims data in...
January 26, 2022 $18.5 million in funding from the Cancer Moonshot will help researchers at USC Norris Comprehensive Cancer Center close the gap in our understanding of colorectal cancer in...
Lyudmila Bazhenova, MD, and Federico Albrecht, MD, detailed the importance of using real-world evidence to inform treatment for patients with EGFR-mutated non–small cell lung cancer.https://embeds.audioboom.com/posts/8012579/embed/v4 As part of its Between...
The Palantir Certification Program will provide an opportunity for users to highlight their Foundry knowledge, skills, and abilities, while their employers will be able to accelerate their transformation by identifying...
– Hyundai Heavy Industries (HHI) Group and Palantir Technologies to establish a big data platform for HHI Group’s core businesses – Palantir Technologies and Hyundai Heavy Industries plan to form a joint...
DENVER & BOSTON–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (“Dewpoint”), the leading biomolecular condensates company, today announced a...
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.comT&Cs and Copyright...
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced the presentation of nine company-sponsored abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting being held December 11-14,...